C. K. Mutuluuza

Identification of a host gene subset related to disease prognosis of HIV-1 infected individuals.

Shin-ichi Hashimoto, Kouji Matsushima, Kazunori Oishi, 2004, International immunopharmacology.

48 week virological response to a triple nucleoside/nucleotide analogue regimen in adults with HIV infection in Africa within the DART trial.

P. Kaleebu, P. Mugyenyi, D. Yirrell, 2005 .

Place-of-care manufacturing of gene therapies.

V. Mathews, R. Orentas, B. Dropulić, 2022, The Lancet Haematology.